<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>-inducing protein S100A4 was found to be a prognostic indicator for the development of metachronous <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>S100A4 expression levels correlate with the formation of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and shorter patients' survival </plain></SENT>
<SENT sid="2" pm="."><plain>Inhibition of S100A4 expression in patients might therefore result in decreased <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> formation and prolonged survival </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we used shRNA expression plasmids to inhibit S100A4 expression in the <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines HCT116, SW620 and DLD-1 </plain></SENT>
<SENT sid="4" pm="."><plain>Cell lines with reduced S100A4 expression showed reduced cell migration and invasion in vitro </plain></SENT>
<SENT sid="5" pm="."><plain>The knock-down of S100A4 expression also led to significantly diminished formation of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> when intrasplenically transplanted in mice (P = 0.004) </plain></SENT>
<SENT sid="6" pm="."><plain>We then focused on the therapeutic potential of systemically applied shRNA expression plasmids acting on S100A4 via repeated hydrodynamics-based tail vein injection of plasmid DNA </plain></SENT>
<SENT sid="7" pm="."><plain>Mice, intrasplenically transplanted with HCT116 cells and treated systemically with S100A4‑shRNA plasmids, showed a decrease of S100A4 and MMP9 expression levels, resulting in significantly reduced <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (P = 0.005) </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, we show for the first time the intratumoral knock down of S100A4 via systemic application of S100A4‑shRNA plasmid DNA, which restricts <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> formation in a xenografted mouse model of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>